Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

435 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Bromocriptine: old drug, new formulation and new indication.
Holt RI, Barnett AH, Bailey CJ. Holt RI, et al. Among authors: barnett ah. Diabetes Obes Metab. 2010 Dec;12(12):1048-57. doi: 10.1111/j.1463-1326.2010.01304.x. Diabetes Obes Metab. 2010. PMID: 20977575 Review.
Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study.
Davies MJ, Donnelly R, Barnett AH, Jones S, Nicolay C, Kilcoyne A. Davies MJ, et al. Among authors: barnett ah. Diabetes Obes Metab. 2009 Dec;11(12):1153-62. doi: 10.1111/j.1463-1326.2009.01154.x. Diabetes Obes Metab. 2009. PMID: 19930005 Free PMC article. Clinical Trial.
The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study).
Barnett AH, Krentz AJ, Strojek K, Sieradzki J, Azizi F, Embong M, Imamoglu S, Perusicová J, Uliciansky V, Winkler G. Barnett AH, et al. Diabetes Obes Metab. 2008 Dec;10(12):1239-47. doi: 10.1111/j.1463-1326.2008.00894.x. Epub 2008 May 20. Diabetes Obes Metab. 2008. PMID: 18494813 Clinical Trial.
435 results